In the News


If you require additional information, please contact James A. Anderson, Chief Operating Officer, +1 314-615-6930 or +1 877-EYE-MITO (877-393-6486) Ext. 3.
 

PDF files require Adobe Reader (free download)

Mobius Therapeutics™ Receives Key Mitosol® Approval for 2014 (13 Jan 2014)
Read Full Article >>

 

Bill on Drug Compounding Clears Congress a Year After a Meningitis Outbreak (18 Nov 2013)
By: Sabrina Tavernise
New York Times
Read Full Article >>

 

Mobius to Double Sales Force Following $5 Million Funding Round (10 Oct 2013)
Read Full Article >>

 

Lethal Medicine Linked to Menengitis Outbreak (10 Mar 2013)
View Video >>

 

Mobius Therapeutics™ Gets Payment Indicator for Mitosol®  (12 Mar 2013)
View Article >>

 

Mobius Therapeutics™ Receives Payment Indicator for Reimbursement of Mitosol®  (11 Mar 2013)
Download >>

 

Mobius Therapeutics™ Provides Update on the Recent Recall of Two Lots of Mitosol®  (20 Feb 2013)
Download >>

 

OIS/AAO 2012 Executive Summary: Eye on Innovation  (2012)
View Report >>

 

Mobius Therapeutics™ President Ed Timm Presents at the Ophthalmology Innovation Summit   (26 Jan 2013)
View Video >>

 

Mobius Therapeutics™ Issues a Voluntary Recall of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use   (10 Jan 2013)
Download >>

 

Mobius Therapeutics™ Announces Assignment of HCPCS Code for Mitosol®   (8 Nov 2012)
Download >>

 

Mobius Therapeutics™ Commences First Shipments of New Glaucoma Drug   (21 June 2012)
Download >>

 

Mitosol/Mobius Therapeutics Press Conference   (29 Feb 2012)

Download >>

 

Mobius Therapeutics™ Receives Final FDA Approval for New Glaucoma Drug   (9 Feb 2012)

Download >>

 

Mobius and Synergetics reshape St. Louis region   (9 Feb 2012)

Download >>

 

Mobius Therapeutics™ Granted Orphan Drug Designation for Refractive Indications   (6 Jun 2011)

Download >>

 

Mobius Therapeutics™ Wins FDA Backing for Drug   (6 Feb 2011)

Download >>

 

Mobius Therapeutics™ Receives Investment From BioGenerator   (4 Feb 2011)

Download >>

 

Mobius Therapeutics™ Granted Orphan Drug Designation for Cornea Indication   (21 Jan 2011)

Download >>

 

Mobius Therapeutics™ Awarded Grant   (8 Nov 2010)

Download >>

 

Mobius Therapeutics™ Awarded Key Patent   (21 Jun 2010)

Download >>

 

Mobius Therapeutics™ Wins Best Business Plan Competition   (2 Jun 2010)

Download >>

 

Mobius Therapeutics™ Granted Orphan Drug Designation   (23 Jan 2008)

Download >>